Sutro Biopharma: Focused on developing next generation antibody drug conjugates (ADCs) and multi-specific antibody-based therapeutics for cancer therapy. The company’s discovery and development efforts are driven by its scalable cell-free protein expression platform (Xpress CF) that enables rapid and systematic evaluation of protein structure-activity relationships. Sutro has three wholly-owned ADCs that are on clinical pathways and three high value collaborations with BMS, Merck, and EMD Serono. STRO-001, anti-CD74 ADC, for multiple myeloma and lymphomas is in Phase 1 and showed encouraging initial safety data at EHA 2019. STRO-002 for ovarian and endometrial cancer is also in a Phase 1 trial. At the AACR-NCI-EORTC conference in October 2019, STRO-002 data showed it was well tolerated and demonstrated early anti-tumor activity in patients with advanced R&R ovarian cancer. Additional Phase 1 dose escalation data for both programs are expected in 2020.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Oncology
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
Website:
Address:
310 Utah Ave
Suite 150
South San Francisco, CA 94080
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Sutro Biopharma, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 10.33 2,368,392 20.06 Stakes 2020-05-22
SV Health Investors LLC 7.96 1,824,542 15.45 13F 2020-03-31
Citadel LP 6.76 1,549,354 13.12 13F 2020-03-31
Eventide Asset Management LLC 5.61 1,285,975 10.89 13F 2020-03-31
Samsara Biocapital LLC 4.91 1,125,579 9.53 13F 2020-03-31
The Vanguard Group, Inc. 3.24 743,643 6.30 Funds 2020-05-31
Tekla Capital Management LLC 2.80 641,268 5.43 13F 2020-03-31
Camber Capital Management LP 2.62 600,000 5.08 13F 2020-03-31
BVF, Inc. 2.07 475,482 4.03 13F 2020-03-31
VV Manager LLC 2.03 464,863 3.94 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.